Jersey Launches £200,000 HFpEF Trial Using Iron Injections and Smart Devices
Updated
Updated · BBC.com · Jul 2
Jersey Launches £200,000 HFpEF Trial Using Iron Injections and Smart Devices
3 articles · Updated · BBC.com · Jul 2
Summary
Jersey has opened a £200,000 clinical trial for patients with heart failure with preserved ejection fraction, testing whether intravenous iron can ease symptoms and improve exercise capacity.
For 14 weeks, participants will wear a smart ring and a thigh patch that continuously track heart rate, step count, physical activity and sit-to-stand movement, replacing reliance on one-off six-minute walk tests.
Dr Aaron Henry said the cloud-linked device data could show more clearly whether treatment is working and help tailor care for a group that is often elderly, including patients in their 70s, 80s and 90s.
Digital Jersey funded the study through its Impact Jersey Fund, arguing the island can serve as a testing ground for digital health tools that could improve outcomes and put Jersey at the forefront of new techniques.